Literature DB >> 9852225

Identification of a neurotrophic sequence in erythropoietin.

W M Campana1, R Misasi, J S O'Brien.   

Abstract

Erythropoietin (Epo) is a hematopoietic factor that facilitates erythroid progenitor cell proliferation and differentiation. Recently, trophic effects of Epo have been observed in central cholinergic neurons. We have confirmed the neurotrophic factor activity of Epo and moreover, demonstrated sprouting and signaling by Epo in neural cells. Further, we have identified a 17-mer peptide sequence (epopeptide AB) in Epo (AEHCSLNENITVPDTKV) with activity similar to that of the holoprotein. This peptide induces differentiation and prevents cell death in both murine NS20Y and human SK-N-MC neuroblastoma cell lines. However, epopeptide AB does not promote the proliferation of erythropoietic cell lines or mouse primary spleen cells. The biological activities in neural cells were blocked by the addition of an antibody to the extracellular domain of the Epo receptor, indicating that the bioactive effects of epo-peptide AB in neural cells are Epo receptor mediated. Both epopeptide AB and Epo stimulated phosphorylation of ERKs in PC12 cells. When epopeptide AB or Epo was locally injected into mice, the frequency of motor end plate sprouting in adjacent muscles increased in a manner similar to that induced by CNTF. These findings indicate that neural cells and not hematological cells respond to a peptide sequence within erythropoietin and suggests that Epo may have separate domains for neurotrophic and hematotrophic function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852225     DOI: 10.3892/ijmm.1.1.235

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  25 in total

Review 1.  A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue Protection.

Authors:  RuiRong Yuan; Bo Wang; Wei Lu; Yasuhiro Maeda; Peter Dowling
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  A randomized, masked study of weekly erythropoietin dosing in preterm infants.

Authors:  Robin K Ohls; Mashid Roohi; Hannah M Peceny; Ronald Schrader; Ryann Bierer
Journal:  J Pediatr       Date:  2011-12-03       Impact factor: 4.406

3.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.

Authors:  A L Sirén; M Fratelli; M Brines; C Goemans; S Casagrande; P Lewczuk; S Keenan; C Gleiter; C Pasquali; A Capobianco; T Mennini; R Heumann; A Cerami; H Ehrenreich; P Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

4.  Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin.

Authors:  Michael Brines; Nimesh S A Patel; Pia Villa; Courtenay Brines; Tiziana Mennini; Massimiliano De Paola; Zubeyde Erbayraktar; Serhat Erbayraktar; Bruno Sepodes; Christoph Thiemermann; Pietro Ghezzi; Michael Yamin; Carla C Hand; Qiao-wen Xie; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-01       Impact factor: 11.205

5.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

6.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

7.  Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways.

Authors:  Weike Mao; Chikao Iwai; Jiahao Liu; Shey-Shing Sheu; Michael Fu; Chang-Seng Liang
Journal:  J Mol Cell Cardiol       Date:  2008-05-27       Impact factor: 5.000

8.  Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

Authors:  Michael Brines; Giovanni Grasso; Fabio Fiordaliso; Alessandra Sfacteria; Pietro Ghezzi; Maddalena Fratelli; Roberto Latini; Qiao-Wen Xie; John Smart; Chiao-Ju Su-Rick; Eileen Pobre; Deborah Diaz; Daniel Gomez; Carla Hand; Thomas Coleman; Anthony Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-29       Impact factor: 11.205

9.  Erythropoietin promotes Schwann cell migration and assembly of the provisional extracellular matrix by recruiting beta1 integrin to the cell surface.

Authors:  Gen Inoue; Alban Gaultier; Xiaoqing Li; Elisabetta Mantuano; George Richardson; Kazuhisa Takahashi; W Marie Campana
Journal:  Glia       Date:  2010-03       Impact factor: 7.452

10.  Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.

Authors:  Robert E Schmidt; Karen G Green; Dongyan Feng; Denise A Dorsey; Curtis A Parvin; Jin-Moo Lee; Qinlgi Xiao; Michael Brines
Journal:  Exp Neurol       Date:  2007-10-29       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.